LIGAND PHARMACEUTICALS INCORPORATED Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value of $270.04 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate · last filed 2026-08-07
- 2026-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $270.04M.
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $588.06M.
- 2025-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $487.80M.
- 2025-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $477.06M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value |
|---|---|
| 2026-06-30 | $270.04M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $588.06M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $487.80M 10-K · filed 2026-02-27 |
| 2025-09-30 | $477.06M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $142.86M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $129.66M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $140.26M 10-K · filed 2025-02-28 |
| 2024-09-30 | $95.81M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $76.92M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $127.92M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $68.90M 10-K · filed 2024-02-29 |
| 2023-09-30 | $78.00M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $95.00M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $134.64M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $59.80M 10-K · filed 2023-02-28 |
| 2022-09-30 | $9.40M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $9.40M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $16.41M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $136.22M 10-K · filed 2022-02-28 |
| 2021-09-30 | $99.48M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $81.37M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $101.49M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $168.75M 10-K · filed 2021-02-24 |
| 2020-09-30 | $143.56M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $488.41M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $471.82M 10-Q · filed 2020-05-08 |